Get the signals worth reading in your inbox

Email address

By subscribing, you agree to our privacy policy.

About Copyright PrivacyComplaints RSS

Swiss startup Atlas Bio secures $12.5M to tackle drug… · Nvdium

←Back to feed

Home/Startups/Article

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing

CCate Lawrence·Tech.euPublished Oct 27, 2026, 09:25 PM· 5 min read

What happened

Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne...

Was this useful?

Read original↗

Share this article

Go deeper

Lovable apps expose sensitive user data, researchers findSifted
Professor James Whittington and Dr Ruairidh Battleday unveil breakthrough from stealth frontier AI labSifted
Ex-LocalGlobe partner closes $17m debut fundSifted
China’s Largest Startup Deal Ever Lifts Global Venture Funding To $59B In OctoberCrunchbase News
Riga-based Unitoq raises €155K in pre-seed to make real estate investment more accessibleTech.eu
CyberKord raises €2.7M to automate IT and cybersecurity operations with AITech.eu